Board of Management

Chairman



  • Mr André GOIG, Regional Director, EAME, Syngenta Seeds SAS

Vice-Chairs



  • Mr Frederic ARBOUCALOT, Chair of the EuropaBio Agri-Food Council; Head of the Seeds Business Operations, Bayer CropSciences S.A.

  • Mr Emmanuel CHANTELOT, Chair of EuropaBio Healthcare Biotechnology Council; Head of International Government Relations and Public Affairs, Shire

  • Mr. Ricardo GENT, Chair of EuropaBio National Assocaitions Council; Executive Director of the German Association of Biotechnologies (DIB)

  • Mr. Thomas Reese SAYLOR, Chair of EuropaBio SME Platform; Chief Executive Officer, Arecor Ltd. representing BIA

  • Mr Stephan TANDA, Chair of EuropaBio Industrial Biotechnology Council; Board Member Royal DSM 

Treasurer




  • Mr. Ian HUDSON, President EMEA, DuPont de Nemours International sàrl.

Members of the Board



  • Mr Mahon BRENNAN, Western Europe Seeds and Traits Director, Monsanto

  • Mrs. Carmen EIBE GUIJARRO, representing ASEBIO

  • Mr. Marcel DANIËLS, Vice President of Government Affairs and Policy for the Europe & Canada Region, Merck Serono

  • Mr. Robin EVERS, Senior Vice President Regulatory Affairs, NovoNordisk

  • Dr. Peter HEINRICH, representing BIO Deutschland e.V.

  • Dr. Carlo INCERTI, Sr Vice President, Head Global Medical Affairs, representing Genzyme Corporation

  • Dr. Harald LAUKE, President Specialty Chemical Research, representing BASF SE

  • Mrs. Petra LAUX, Head of Global Public and Goverment Affairs, representing Novartis

  • Mrs. Jenny LOUGHNEY, Director, representing the Irish BioIndustry Association (IBIA)

  • Mr. Jeremy MORGAN, Vice President for Diabetes, International, Lilly

  • Mr. Thomas NAGY, Executive Vice President, representing Novozymes

  • Mrs. Maria Luisa NOLLI, Founder & CEO of Areta International s.r.l., representing Assobiotec

  • Dr. Walter PFEFFERLE, Senior Vice President Business Line Bioproducts, representing Evonik industries AG

  • Prof. Dr. Lukas PFISTER, Executive Director European Public Policy, representing MSD (Europe)

  • Dr. Andrea RAPPAGLIOSI, Vice President Market Access, Vaccine Advocacy & Medical Affairs, representing Sanofi Pasteur MSD

  • Mrs. Pascale RICHETTA, Vice-President, Western Europe & Canada Operations, representing AbbVie

  • Prof. Dr. Arjen VAN TUNEN, CEO, representing Keygene

  • Mrs. Annemiek VERKAMMAN, Managing Director, representing HollandBIO
     

  • Mrs. Nathalie MOLL, Secretary General, representing EuropaBio - ex-officio

 


Last update: 10 July 2014